Key points are not available for this paper at this time.
The study aims to investigate the efficacy of titanium dioxide (TiO2) nanoparticle coating on stainless steel 316L (SS 316L) orthopaedic implants to enhance their biocompatibility, osseointegration, and durability. The TiO2 nanoparticles were synthesized via the hydrothermal method and extensively characterized for composition, crystallinity, and morphology using techniques such as X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), and scanning electron microscopy (SEM) with energy dispersive X-ray analysis (EDX), corroborated by elemental mapping. SEM and XRD analyses revealed the synthesized nanoparticles have a spherical shape and an average size of approximately 23 nanometres. The synthesized TiO2 nanoparticles were uniformly coated on SS 316L substrates using the spin coating technique, as confirmed by SEM images. Cell viability of the synthesized TiO2 nanoparticles, as well as uncoated and TiO2 nanoparticle-coated SS 316L substrates, was evaluated using the MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) assay against the NIH-3T3 mouse embryonic fibroblast cell line. The results demonstrated that the TiO2 nanoparticle-coated SS 316L substrate showed a significant increase of 22.87% in cell viability as compared to the uncoated SS 316L substrate. A ball-on-disc tribometer was employed to assess wear and friction resistance at various speeds, viz., 150 rpm, 300 rpm, and 450 rpm, under 30N load conditions for five minutes. The results collectively indicate a substantial improvement in the performance of TiO2 nanoparticle-coated SS 316L substrates for orthopaedic applications.
Jadon et al. (Tue,) studied this question.